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The  characterization  and  evaluation  of antigen-induced  suppressor  T  (Ts) 1 
cell networks  have considerably evolved in  the  last several  years (1-4).  While 
there are now a variety of ways to induce such Ts cells, one of the most intriguing 
approaches has been to intravenously inject ligand-derivatized lymphocytes into 
naive recipients, and to later use these recipients as suppressor cell donors (1, 3). 
This technique has  been successfully used  with  haptens  (5-7),  polysaccharides 
(8), and immunoglobulins (9,  10) in mice. While suppressor networks generated 
by ligand-derivatized lymphocytes can have features that are inherently unique 
to  a  particular  system,  they  also  tend  to  share  several  characteristics.  They 
typically involve several sets of sequentially activated Ts cells with complementary 
specificities; they often operate under H-2 and Igh-1 restrictions; and they usually 
secrete soluble suppressor factors that mediate complex interactive functions (1, 
3,  11). 
We  have  used  an  experimental  model  of interstitial  nephritis  (anti-tubular 
basement membrane [anti-TBM] disease) to determine if tubular antigen-deriv- 
atized lymphocytes induce or activate a disease-protective Ts cell network in an 
autoimmune setting.  Interstitial  nephritis can be induced in prototype SJL and 
BALB/c mice with an  injection of renal TBM in adjuvant (12-14).  Anti-TBM 
antibodies (Ab) appear by 10 d  and interstitial lesions typically develop by 6-10 
wk.  Susceptibility to disease is defined by genes in H-2K and Igh-1  (15), and is 
mediated by an effector T  cell repertoire containing cytotoxic and delayed-type 
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hypersensitivity  (DTH)-reactive,  Lyt-2  +,  RE-Id  +  T  lymphocytes  (RE-Id,  anti- 
TBM Ab eluted from nephritic kidneys) (12,  15). Such Lyt-2  + lymphocytes are 
H-2K restricted, will acutely transfer disease, can be found within the interstitial 
infiltrate, and produce DTH reactions to tubular antigen when transferred into 
naive recipients (15).  These H-2K-restricted effector T  cells are only found in 
disease-susceptible  mice,  and  the  DTH  response  they  produce  is  a  reliable 
measure of effector T  cell function leading to renal injury. 
We now report that tubular antigen-derivatized lymphocytes activate a Ts cell 
network that markedly attenuates tubular antigen-reactive DTH  effector cells 
and  the  development of interstitial  lesions.  These  suppressor  cells function  in 
both the afferent and efferent phases of the anti-TBM immune response.  This 
network is  composed of RE-Id  + Ts-I  cells (antigen-binding,  afferent phase  Ts 
cells) which, in the presence of antigen, induce RE-Id-binding Ts-2 cells (idiotype- 
binding,  effector  phase  Ts  cells)  that  are  restricted  by  I-J  and  Igh-V  gene 
products. 
Materials and Methods 
Animals.  SJL (H-2S; Igh-lb), A.SW (H-2~; Igh-le), B10.A (H-2a; Igh-lb), B10.A(5R) (Hb 
2~5; Igh-1 b), and BALB/c (H-2d; Igh-1 a) mice were purchased from The Jackson Labora- 
tory, Bar Harbor, ME.  B10.S (H-2S; Igh-lb), B10.S(9R) (H-2'4;  Igh-lb), B10.TBR2 (Hb 
2at2; Igh-lb), and B10.HTT (H-2~3; Igh-1 b) mice were obtained from Dr. Chella David, 
Mayo Clinic, Rochester, MN. SJA/20 (H-2S; Igh-l") and BAB/14 (H-2d; Igh-Va/C  b) mice 
were obtained  from  Dr.  Roy  Riblet,  Institute  for Cancer  Research,  Fox  Chase,  PA. 
BI0.S(8R) (H-2as; Igh-1 b)  mice were a  generous gift from  Dr.  Martin  Dorf,  Harvard 
University,  Boston,  MA;  C.B-20  (H-2d;  Igh-1 b)  mice  were  from  Dr.  Carol  Cowing, 
University of Pennsylvania; and  BALB.K (H-2k;  Igh-1 a)  mice  were  from  Dr.  Robert 
Korngold, Wistar Institute, Philadelphia, PA. (SJL x  B10.A)F, hybrids were bred by the 
investigators. 
Preparation of  Renal Tubular Antigen (RTA).  Rabbit renal tubular basement membranes 
and rabbit liver basement membranes were isolated by a differential sieving technique, 
sonicated, lyophilyzed, and stored at -70°C (12). Soluble renal tubular antigen (SRTA) 
and soluble liver antigen (SLA) were made from these lyophilyzed membranes by colla- 
genase digestion, as previously described (15). The nephritogenic moiety in this digestion 
is 3M-1 glycoprotein (16). 
Induction of Disease.  Groups of mice were immunized with 2 mg of RTA in complete 
Freund's adjuvant (CFA) by footpad and/or subcutaneous injection (15).  Control mice 
received SLA in CFA, or CFA alone. Some groups were also treated with 30 mg/kg of 
cyclophosphamide 24 h after immunization (17). 
Induction and Elicitation of DTH Responses.  DTH responses to SRTA were induced by 
subcutaneously immunizing mice with RTA in CFA (15).  6 d later groups of mice (four 
to six mice per group) were challenged in one footpad with 25 #g of soluble antigen in 
25 #1 of phosphate-buffered saline (PBS). Swelling as an index of DTH was measured 24 
h later using a spring-loaded engineer's micrometer (Schlesingers For Tools Ltd., Brook- 
lyn, NY).  The magnitude of swelling was expressed as the mean increment, in inches × 
10  -3 + SEM, between the antigen-challenged footpad and the other footpad injected with 
PBS. All measurements were cage-blind. 
Preparation of SRTA-derivatized  Cells.  SRTA was coupled to normal syngeneic spleen 
cells using a carbodiimide procedure as previously described (10, 18). Briefly, spleen cells 
from selected strains of mice were treated with Tris-buffered 0.83% ammonium chloride 
(pH 7.2) to lyse the erythrocytes. 4 ×  108 cells were incubated with  1 mg SRTA and 25 
mg 1-ethyl 3-(3-diethylaminopropyl)carbodiimide in  1 ml 0.9% saline.  The mixture was 
gently rotated at 4°C for 90 min and then washed three times with normal saline.  Under 
these conditions, 15-18 #g of SRTA (trace labeled with 125I) was  bound to 5 ×  107 viable NEILSON  ET  AL.  217 
cells.  Cell viability at the end of this coupling procedure averaged 80%  by trypan blue 
exclusion. 5  x  10 v tubular antigen-coupled cells were intravenously injected into naive 
recipients and, after 7 d, the spleens of these recipients were used as a source of donor 
Ys. 
Adoptive  Transfer of Suppression.  5  x  107 viable splenic Ts cells from mice that had 
received SRTA-derivatized cells 7 d earlier were intravenously transferred into recipients 
either on the day of their immunization with RTA in CFA (afferent phase) or 5-7 d after 
such an immunization (effector phase) (19).  Selected groups of mice receiving afferent 
phase Ts cells were challenged for DTH 6 d  later, and mice receiving effector phase Ts 
cells were challenged for DTH 36 h later. Other groups of mice received similar Ts cells 
and were followed 8-10 wk for the histologic development of  disease. In some experiments 
the transferred  inoculum of Ts cells were pretreated  with antibodies plus  C'  or were 
separated into subpopulations by indirect panning. 
Preparation of T Cells and Their Subpopulations.  Cell suspensions were depleted of T 
lymphocytes with monoclonal anti-Thy-l.2 antibody (from Jlj hybridoma [20] provided 
by Dr. Jon Sprent,  University of Pennsylvania) and a  mixture of rabbit and guinea pig 
complement (12,  15). Anti-Lyt-l.2 monoclonal antibody (from C3PO.7 hybridoma [21], 
prepared by Dr. Jan Klein,  Max Planck Institute,  Tubingen,  Federal  Republic of Ger- 
many), anti-Lyt-2 monoclonal antibody (from 3.168.8  hybridoma [22], provided by Dr. 
Frank Fitch,  University of Chicago, Chicago,  IL), and anti-L3T4 monoclonal antibody 
(from GK-1.5 hybridoma [23], provided by Dr. Fitch) were used with a mixture of guinea 
pig  and  rabbit  complement  for  T  cell  subpopulation  depletion.  Anti-I-J  s  ([A.TL  × 
B10.S(9R)]F~  anti-B10.HTT;  NIH Y1-9-09-19-01) and anti-I-J  k ([BI0.A(3R) ×  A.BY]Fj 
anti-B 10.A(5R); NIH Y 1-0-01-09-02) antibodies were used at optimal concentrations with 
a mixture of rabbit and guinea pig complement to deplete I-J-bearing lymphocytes (17). 
Polymorphic idiotypes (RE-Id) were prepared by acid-eluting anti-TBM  Ab  from SJL 
nephritic kidneys using glycine HCI (pH 2.6) (15, 18). RE-anti-Id antibodies were prepared 
by hyperimmunizing a  rabbit with  RE-Id. The serum containing RE-anti-Id antibodies 
was extensively absorbed against SJL gamma globulin and normal mouse kidney eluates 
coupled to activated Sepharose 4B. The specificity of binding was determined by compet- 
itive inhibition radi0immunoassay using SRTA, RE-Id, control antigen, and antibody as 
previously described (15). By this radioimmunoassay, the RE-anti-Id antisera was specifi- 
cally inhibited by RE-Id but not by SRTA. In direct binding studies, RE-anti-Id also did 
not bind to normal mouse kidney eluates.  The  RE-anti-Id antisera was used at a  final 
concentration of 1:200 in the presence of rabbit and guinea pig complement to deplete 
RE-Id  + cells (15). 
Selected aliquots of cells were also purified using panning separation techniques (15, 
18). 3 x  107 erythrocyte-free spleen cells were first incubated in 60 ×  15 mm polystyrene 
culture dishes previously coated with affinity-purified rabbit anti-mouse Ig (Zymed Inc., 
San  Francisco, CA) at  1 mg/ml. The incubations were performed at 22°C  for 45  rain 
interrupted once at 20 min by gentle swirling. The nonadherent cells were gently removed 
at  45  rain  in  three  washes,  while adherent  cell  removal required  cold media,  30  min 
incubation  at 4°C,  and vigorous pipetting.  Nonadherent cells routinely contained 92- 
96%  T  cells by indirect  fluorescence criteria.  In some experiments,  such  T  cells were 
further incubated with optimal concentrations of RE-Id at 4°C for 30 min. After three 
washes the  cells were panned  on dishes  previously coated with  affinity-purified rabbit 
anti-mouse IgG. Adherent and nonadherent cells were then used in selected experiments. 
In other studies panning-purified T  cells were also separated on SRTA-coated dishes (1 
mg/ml). 
Assessment of Renal Disease.  Kidney tissue was prepared for direct immunofluorescence 
and light microscopy by the standard methods of this laboratory. The degree of interstitial 
involvement was qualitatively graded from 0  to 4 on coded sections and expressed as a 
mean +  SEM for each group (12,  15). 
Statistical  Analysis.  Differences  between  experimental  groups  were  determined  by 
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Results 
Assessment and Characterization  of Ts cells that Inhibit Nephritogenic  T Lympho- 
cytes.  We  have previously observed  (15)  that  the  DTH  response  to  SRTA  in 
disease-susceptible  SJL  mice is  a  reliable  measure  of nephritogenic  effector T 
cell function.  The nephritogenic  3M-1  glycoprotein in  RTA  and  SRTA (16)  is 
the  principal  determinant  eliciting  the  DTH  reaction,  since  mice  immunized 
with RTA/CFA  strongly respond to challenge with 3M-l, but only very slightly 
with SRTA-depleted 3M-l, compared with control (manuscript in preparation). 
In the present series of experiments we wished to determine if donor lymphocytes 
(Ts)  from  SJL  mice  primed  with  syngeneic  SRTA-derived  cells  would  subse- 
quently suppress this  DTH  reaction  to tubular  antigen.  In Table I  such donor 
cells substantially inhibited the DTH  response to SRTA when transferred either 
at the time of recipient immunization with RTA in CFA (day 0; afferent phase) 
or  5  d  later  (effector phase  suppression).  Control  cells provided  no  inhibitory 
effect. The specificity of these suppressor cells was further examined (Table II). 
Ts donor cells from mice primed with SRTA-derived lymphocytes, after adoptive 
transfer  on  days 0  and  5,  inhibited  the  DTH  response  to  SRTA  in  recipients 
immunized  with  RTA  in  CFA,  with  no  concomitant  effect  against  purified 
protein derivative (PPD). Such an inhibitory effect was not observed in recipients 
immunized with SLA in CFA, suggesting that the Ts effect was specific for the 
SRTA-reactive response. The phenotype of these Ts cells was determined both 
on day 0  and day 5  (Table  III). Ts donor cells from mice primed with  SRTA- 
derivatized  cells  were  pretreated  with  various antibodies  to  phenotypic  T  cell 
determinants  just  before  adoptive  transfer.  The  results  at  both  time  points 
indicate  that  suppression  was  mediated  by  Thy-l.2 +,  I-J  +  cells.  The  afferent 
phase  suppressor  cell,  however,  was  Lyt-1 +,  L3T4 +,  while  the  effector  phase 
suppressor was Lyt-2  +.  A  variety of functional T  cells in different experimental 
systems  also  express  idiotypic  determinants  that  are  detectable  by  serologic 
analysis (24).  We  have previously observed that  nephritogenic  effector T  cells 
TABLE  I 
Functional Presence of afferent and Effector Phase Suppressor Cells 
Donor cells*  .  Reciryen.~nl. 
lmmumzatlon 
DTH Response to SRTA* 
Afferent  Effector 
(Day 0)  (Day 7) 
--  RTA/CFA  17.1 + 0.68  15.5 ± 2.48 
Ts  RTA/CFA  4.8 +  1.0  4.0 ± 0.4 
Control  RTA/CFA  17.5 + 0.88  16.3 ±  1.2 ~ 
--  CFA  4.7 + 0.4  3.2 ± 0.7 
--  --  4.3  ±  0.5  3.6 ± 0.5 
* 5 X  10  7 donor Ts cells from SJL mice primed with SRTA-derivatized 
lymphocytes were transferred  into recipients either at the time of im- 
munization (afferent phase) or 5 d after immunization (effector phase). 
* Incremental  DTH responses were measured in the recipients in inches 
×  10  -3 + SEM. Recipients were challenged for DTH 6 d after donor 
cell transfer (afferent phase) or 36 h after donor cell transfer (effector 
phase). DTH responses were recorded  24 h after challenge. 
8  p < 0.001 compared with unimmunized controls. NE1LSON  ET  AL. 
TABLE  II 
Specificity of Induction and Effector Phase Suppressor  Cells 
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DTH  Responses after cell transfer  ¢ 
Recipient  Induction (day 0)  Effector (day 7)  Donor cells*  immunization 
SRTA  SLA  PPD  SRTA  SLA  PPD 
--  RTA/CFA  18.0-0.8!  4.8±0.5  18.8±0.8  i  17.8±0.6  !  5.3±0.6  19.3+0,3 t~ 
Ts  RTA/CFA  5.0 ±  1,4  4.0 _  0.6  18.4 4- 2.3  !  4.8 ±  1.4  3.7 4-  1,3  18.0 _  1,7  | 
Ts  SLA/CFA  5.1  ±  0.5  16.5 4- 1.2  j  16.7 4- 1.5  §  --  --  -- 
Control  RTA/CFA  21.0 4- 2,5  !  3.3 ±  0.9  22.0 ---+ 2,0  !  17,0 ±  1,3  !  5.3 -4- 0.6  23.6 ±  4.2  I 
--  CFA  3.0 ±  1.0  3.8 ±  0.3  22.0 ±  1.91  5.0 ±  0.6  5.3 ±  0.3  19.0 4- 0.9! 
--  --  4.1  4-0.6  4.4±0.4  4.0±0.4  5.5±0.3  4.3 ±  0.2  4.8±0.5 
*  5  X  107 donor  Ts cells from SJL mice primed  with SRTA-derivatized  lymphocytes  were transferred  into recipients either at the 
time of immunization (induction phase) or 5 d  after immunization (effector phase). 
t  Incremental  DTH  responses  were  measured  in  the  recipient  in  inches  X  10  ~~ __. SEM.  Recipients  were  challenged  with soluble 
antigens  to produce  DTH  6  d  after  donor cell transfer  (induction  phase) or  36 h  after  transfer  (effector  phase).  DTH  responses 
were recorded 24 h  after challenge. 
Ip<  0.001  compared  with unimmunized controls. 
TABLE  III 
Phenotypic Characterization  of Ts Cells 
Suppressor cell transfers* 
Donor cells  Treatment 
Recipient 
immunization 
DTH Responses to SRTA* 
Afferent (Day 0)  Effector (Day 7) 
__  m 
Ts 
Ts  C' 
Ts  Anti-Thy 1.2 +  C' 
Ts  Anti-Lyt-l.2 +  C' 
Ts  Anti-L3T4 +  C' 
Ts  Anti-Lyt-2 +  C' 
Ts  Anti-J  ~ +  C' 
Ts  Anti-J  k +  C' 
Control 
RTA tCFA 
RTA tCFA 
RTA/CFA 
RTA/CFA 
RTA tCFA 
RTA tCFA 
RTA/CFA 
RTA/CFA 
RTA/CFA 
RTA rCFA 
CFA 
15.0 ___ 0.8 ~  14.0 +  1.2 ! 
3.0 _  2.2  5.0 +  1.0 
4.1 +  0.7  4.8 +  1.3 
15.3_+  1.0  j  15.5 +  1.3 ~ 
15.0 +  1.1 §  4.5 +  0.6 
17.3 +  1.10  6.2 ±  0.9 
7.0 ±  0.4  16.0 ±  0.4  § 
14.8 ... 0.7 !  14.5 ±  0.5 u 
4.0 ±  0.5  4.0 ±  0.4 
17.5 _  1.0 ~  15.0 ±  0.8  ~ 
3.5 ±  0.4  4.8 ±  1.0 
* 5 ×  107 donor Ts cells from SJL mice primed with SRTA-derivatized lymphocytes were transferred 
into  recipients either  at  the  time of immunization  (afferent  phase)  or  5  d  after  immunization 
(effector phase). Some donor cells were pretreated with antibody plus C' before transfer. 
Incremental DTH responses were measured in the recipients in inches x  10 -~ _  SEM. Recipients 
were challenged for  DTH  6  d  after donor  cell transfer  (afferent  phase)  or  36  h  after transfer 
(effector phase). DTH responses were recorded 24 h after challenge. 
§ P <  0.001  compared with CFA controls. 
I P <  0.005 compared with CFA controls. 
are RE-Id + lymphocytes  (15).  We therefore  wished to determine  if either afferent 
or  effector  phase  Ts  cells  express  such  a  specificity.  We  pretreated  donor  Ts 
cells with RE-anti-Id  plus C'  before  adoptive  transfer  (Table  IV). Control  normal 
rabbit  serum  (NRS)  plus  C'  did  not  affect  suppression  on  day  0  or  day  5. 
Treatment  with  RE-anti-Id  plus  C',  however,  eliminated  suppression  on  day  0. 
These  findings  suggest that  only afferent  phase  Ts  cells are  RE-Id +. 
Having  demonstrated  the  existence  and  effect  of  these  Ts  lymphocytes  on 
DTH  reactivity towards  SRTA,  we wished to determine  their ability to influence 
the  histologic  expression  of  interstitial  nephritis.  We  have  previously  (12,  14) 
observed  that  the  lesions  are  progressively  fatal  and  that  renal  function  is 220  SUPPRESSOR  CELL  NETWORKS  IN  INTERSTITIAL  NEPHRITIS 
TABLE  IV 
Effect of RE-Anti-ld on Ts Cell Function 
Donor cells*  Recipient  Treatment 
immunization 
DTH Response after cell transfer* 
Induction  Effector 
(day 0)  (day 7) 
--  RTA/CFA  --  16.8 +  1.1 ~  17.5 4- 0.90 
Ts  RTA/CFA  --  3.7 +  0,7  5.2 4- 0.8 
Ts  RTA/CFA  RE-anti-ld +  C'  16.8 +-- 1.40  4.8 4- 0,6 
Ts  RTA/CFA  NRS +  C'  2.8 --- 1.0  4.7 +  0.6 
Control  RTA/CFA  --  17.5 +  1.0 ~  16.7 4- 1.0 ~ 
--  CFA  --  4.0 +  0.4  4.3 4- 0.3 
* 2.5  x  107 donor Ts cells (panning-purified T  cell fraction) from SJL mice primed with SRTA- 
derivatized syngeneic lymphocytes were transferred into recipients either on the day of immuni- 
zation (induction phase) or 5 d after immunization (effector phase). 
* Incremental DTH responses were measured in the recipient in inches ×  10 -3 4- SEM. Recipients 
were challenged for DTH 6 d after transfer (induction phase) or 36 h after transfer (effector phase) 
and the footpad swelling was recorded 24 h later. 
§ P <  0.001  compared with CFA controls. 
TABLE  V 
Inhibition  of lnterstitial Nephritis With Ts Cells 
Donor cells*  Treatment*  Recipient 
immunization 
Histology  ~ 
Afferent (day 0)  Effector (day 7) 
--  --  RTA/CFA  3.8 -4-- 0.2 (8) 
Ts  --  RTA/CFA  0.3 +  0.2 (15) n  1.1  4- 0.4 (10) n 
Ts  C'  RTA/CFA  0.1  4- 0.1  (9) I  0.8 +  0.4 (7) If 
Ts  Anti-Thy-l.2 +  C'  RTA/CFA  3.3 4- 0.2 (4)  3.1  +  0.2 (4) 
Ts  Anti-l-J' +  C'  RTA/CFA  3.7 4- 0.3 (3)  3.5 4- 0.2 (3) 
Ts  Anti-l-J  k + C'  RTA/CFA  0.0 4- 0.0 (4) II  0.4 4- 0.2 (6) H 
Control  --  RTA/CFA  3.4 4- 0.3 (11)  3.2 4- 0.4 (5) 
--  --  CFA  0.0 4- 0.0 (8) 
* Donor Ts cells were harvested from SJL mice 7 d after priming with syngeneic SRTA-derivatized 
7  lymphocytes. These donor cells were adoptively transferred (5 ×  10  cells per recipient) into SJL 
mice either at the time of immunization (afferent phase) or 5 d after immunization (effector phase). 
* Some donor cells were pretreated with antibody plus C' before transfer. 
§ Recipients were sacrificed 10 wk after immunization and their kidneys were histologically graded 
(0 to 4) and reported as mean 4- SEM (n). 
II  p <  0.001  compared with control. 
significantly decreased  by  16  wk.  In Table  V,  it can  be  observed  that  donor  Ts 
cells  from  mice  primed  with  SRTA-derived  lymphocytes  almost  completely 
blocked  the development  of disease when  they were given at the time of recipient 
immunization  (afferent  phase).  Substantial  inhibition  also  occurred  when  these 
cells were  transferred  7  d  after  immunization  (effector phase).  This  suppressive 
effect was largely abrogated  if the donor  cells were pretreated  with anti-Thy-l.2 
or anti-I-J  s antibodies  plus C'.  Direct immunofluorescence  for kidney-bound  anti- 
TBM  Ab appeared  equally strong  in  groups  with  interstitial  nephritis  and  those 
protected  with  adoptively  transferred  suppressor  cells; by  quantitative  radioim- 
munoassay  a  17%  reduction  in  serum  anti-TBM  Ab  was  observed  in  the  group 
receiving  afferent  Ts cells (data  not shown). NEILSON  ET  AL.  221 
Binding Reactivity of  Afferent and Effector Phase Ts Cells.  One of the interesting 
characteristics of Ts cells, unlike other functional T  cell subpopulations, is their 
ability to bind ligand supports in vitro (6,  25-28). We took advantage of this to 
examine the binding specificity of afferent and effector phase Ts cells from mice 
primed  with  SRTA-derivatized lymphocytes.  Donor  Ts  cells  were  panned  on 
SRTA-coated culture dishes  (Table VI).  We  observed after  separation  that  as 
little as 2  ×  106 SRTA-binding Ts cells inhibited a  DTH  response to SRTA, but 
only in the afferent phase. The separation was largely complete, since 2.5 ×  107 
SRTA-nonadherent  cells inhibited the  DTH  response only during the effector 
phase. The specificity of the SRTA-binding Ts cells was also suggested by their 
failure to  suppress the  DTH  reaction to  PPD.  These cells represented ~2-4% 
of the total starting donor spleen cell number. 
Similar experiments were also performed with donor Ts cells panned to select 
for RE-Id-binding lymphocytes. We observed that  3  ×  106  RE-Id-binding cells 
inhibited a  DTH  response to SRTA  only in the effector phase (Table VII). 2.5 
×  10 v  RE-Id-nonadherent T  cells  were  not able  to  suppress  DTH  under  the 
same conditions, but did inhibit DTH  during the afferent phase.  As above, the 
specificity of this suppression was suggested by the failure of RE-Id-binding  cells 
to inhibit DTH  to PPD. 
The  results obtained to  this point suggest  that  donor  spleen ceils,  7  d  after 
priming with SRTA-derivatized lymphocytes, contain at least two general pop- 
TABLE  VI 
Inhibitory Effect of SRTA-binding Ts Cells 
DTH Responses after cell transfer* 
Suppressor cells*  Dose  Recipient 
transferred  (×107)  immuni-  Induction (day 0)  Effector (day 7) 
zation 
SRTA  PPD  SRTA  PPD 
--  --  RTA/CFA  17.3  ±  1.3  ~  16.3 +- 2.4  ~  18.5  ± 0.9  ~  19.0± 0.6g 
Unfractionated cells  5.0  RTA/CFA  3.8 ± 2.0  15.0 -  0.8 a  5.3 ±  1.2  20.8 ± 2.2  § 
lgplate-adherent B  2.5  RTA/CFA  15.8 ± 0.3 ~  15.8  ± 0.30  18.5  ± 0.9 ~  19.3  ± 0.30 
cells 
Ig plate-nonadher-  2.5  RTA/CFA  5.0 ± 0.4  15.3 ± 0.3 ~  6.0 ± 0.4  18.8  ±  1.00 
ent T cells 
SRTA-adherent T  0.2  RTA/CFA  3.5 _ 0.6  14.2 ±  1.3 n  21.0 ±  1.1~  21.8 ± 0.8 ~ 
cells 
SRTA-nonadherent  0.4  RTA]CFA  15.5  ±  1.4  ~  14.5  ±  1.2  u  18.7  ±  1.3~  21.0 +  1.8  ~ 
T cells 
SRTA-nonadherent  2.5  RTA/CFA  16.3  ± 0.5 °  16.5  ± 0.3 §  6.1 ± 0.7  18.2  ± 0.3 § 
T ceils 
Control cells  5.0  RTA]CFA  17.7- 0.9  §  15.3  ± 0.6 ~  18.2  ± 0.7~  19.0 ± 0.2  ~ 
--  --  --  3.8_+0.3  4.5±2.0  4.1±0.7  3.9±0.4 
* Donor cells from SJL mice primed with SRTA-derivatized  lymphocytes were separated  on anti- 
mouse Ig panning dishes and the nonadherent T cells were then placed on SRTA-coated panning 
dishes. Each of the resulting cell fractions were  transferred into recipients  either at the time of 
immunization  (induction phase) or 5 d after immunization  (effector phase). 
* Incremental DTH responses were measured in the recipients in inches x  10  -3 + SEM. Recipients 
were challenged  for DTH 6 d after donor cell transfer (induction phase) or 36 h after transfer 
(effector phase). DTH responses were recorded 24 h after challenge. 
§ P < 0.001 compared with unimmunized  controls. 
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TABLE  VII 
Inhibitory Effect of RE-Id-binding Ts Cells 
Donor cells* 
DTH  response after cell transfer* 
Dose  Recipient 
(x 107)  immuniza-  Afferent (day 0)  Effector (day 7) 
tion 
SRTA  PPD  SRTA  PPD 
--  --  RTA/CFA  17.3 ±  1.20  16.6 ±  0.3  17.3 ±  0.3 §  16.0 ±  0.6 
Unfractionated cells  5.0  RTA/CFA  4.6 ±  0.7  17.2 +  0.7  4.0 +  1.0  16.8 ±  0.6 
Ig-plate-adherent B  2.5  RTA/CFA  18.3 ±  0.9  §  t6,8 ±  0.3  16.6 ±  0.3 §  15.6 ±  0.3 
cells 
Ig-plate-nonadher-  2.5  RTA/CFA  6.5 ±  1.2  17.8 ±  0.5  5.0 -+ 0.6  17.6 ±  0.3 
ent T  cells 
RE-Id-adherent T  0.3  RTA/CFA  19.6 ±  1.9  ~  17.3 ±  1.0  4.3 ±  1.2  17.2 ±  1.8 
cells 
RE-Id-nonadherent  0.3  RTA/CFA  19.0 ±  2.0  ~  16.8 ±  0.4  16.6 ±  0.9  §  15.0 ±  0.6 
T  cells 
RE-Id-nonadherent  2.5  RTA]CFA  5.4 ±  0.8  17.2 ±  0.9  16.3 ±  0.8~  16.3 +  0.9 
T  cells 
Control cells  5.0  RTA/CFA  18.6±  1.0  ~  17.3±  1.4  19.3±0.6 ~  17.3±0.4 
--  --  CFA  4.8 ±  0.4  18.3 ±  0.3  5.0 ±  0.6  18.0 ±  1.1 
* Donor cells from SJL  mice primed with SRTA-derivatized lymphocytes were  separated on anti- 
mouse lg panning dishes and the nonadherent cells were  then incubated with  RE-Id Ab for  30 
rain.  After  washing, a  second  panning was  performed  on  anti-mouse IgG  dishes.  Each  of the 
resulting cell fractions was transferred into recipients either at the time of immunization (afferent 
phase) or 5 d  after immunization (effector phase). 
* Incremental DTH  responses were measured in the recipients in inches X  10  -n _  SEM.  Recipients 
were  challenged  for  DTH  6  d  after donor  cell  transfer (afferent  phase) or  36  h  after  transfer 
(effector phase). DTH  responses were recorded 24 h  after challenge. 
§ P  <  0.001  compared with CFA controls. 
ulations of suppressor cells: (a) L3T4 +, 1-J  +, RE-Id  +, SRTA-binding suppressor 
cells that only operate at the time of immunization  with RTA in CFA (afferent 
phase) and will  be referred to as Ts-1  cells, and (b) Lyt-2  ÷, I-J  +, RE-Id-binding 
suppressor cells that  only operate after immunization  (effector phase) and  will 
be referred to as Ts-2 cells. 
Ts-2  Cells  Do  Not  Induce  Auxiliary  Ts-3  Cells  in  Immunized  Recipients.  An 
auxiliary suppressor lymphocyte, or Ts-3 cell, has also been described in a variety 
of other suppressor cell systems (1,  3).  This Ts-3 cell has typically been charac- 
terized as I-J ÷ and cyciophosphamide (CTX) sensitive. It or its precursor appears 
in the antigen-immunized  host by 5 d, but the Ts-3 cell is only fully activated by 
the addition of Ts-2 lymphocytes. The Ts-3 effect is nonspecific and is thought 
to  be a  final  effector cell  in  some  suppressor  networks  (1,  3).  We  wished  to 
determine if Ts-3 cells were also present in our system. Ts-2 cells were transferred 
into recipients immunized with tubular antigen, some of which had been treated 
with CTX 24 h after immunization (17). Effector phase suppression of DTH was 
measured on day 7. The results (Table VIII) indicate that CTX treatment of the 
recipient  did  not  eliminate  the  ability  of Ts-2  cells  to  suppress.  In  another 
experiment,  DTH-reactive  lymphocytes pretreated  with  anti-I-J s plus  C'  were 
co-transferred  into  naive  recipients  with  Ts-2  cells (17).  Effector phase  DTH 
under these conditions was also still  inhibited compared with I-J allele controls NEILSON  ET  AL.  223 
TABLE  VIII 
Failure to Observe CTX-sensitive Ts-3 Cells 
Dose  Recipient  DTH Response to 
Donor cells*  (X 106)  immunization  SRTA  § 
--  --  RTA  20.0 _+ 0.6 
RTA/CTX*  22.6 +  1.8 
RE-Id Adherent  0.8  RTA  11.3 _-_ 1.71 
(Ts-2)  RTA/CTX  11.6 _+ 1.91 
RE-Id Nonadherent  4.0  RTA  26.0 + 2.1 
(non-Ts-2)  RTA/CTX  25.6 --. 0.9 
Control ~  4.0  RTA  23.7 + 0.6 
RTA/CTX  27.6 +  1.4 
--  --  CFA  9.3 --- 1.8 
CFA/CTX  10.0 -+ 0.5 
* Donor  ceils separated  into subpopulations  were adoptively transferred into 
syngeneic recipients 5 d after immunization (effector phase). 
* Some recipients were given CTX (30 mg/kg) 24 h after immunization. 
§ Incremental  DTH responses were measured in the recipient in inches x  10  -3 
-+ SEM. Recipients were  challenged  for DTH 36 h after transfer and the 
footpad swelling was recorded 24 h later. 
I Controls are a pooled average from all groups. 
i p < 0.005 compared to controls. 
(data not shown).  From these two experiments we were not able to identify the 
functional presence of Ts-3 cells in our system. 
Ts-1 Cells Induce Ts-2 Lymphocytes.  From  the previous experiments it would 
seem that Ts-2 cells are the final effector suppressor cell in the network described 
in this report.  Because Ts-1  cells operate earlier in the suppressive scheme and 
share  complementary determinants  with  Ts-2,  we wished  to  determine  if Ts-1 
cells  would  induce  the  Ts-2  repertoire.  3  x  106  syngeneic  Ts-1  cells  were 
cotransferred into naive recipients with or without SRTA (100 #g). Control ceils 
were normal lymphocytes because the non-SRTA-binding lymphocytes from the 
Ts-1 preparation contained Ts-2 cells. Only the donor cells harvested from mice 
primed  with  Ts-I  cells  plus  SRTA  were  able  to  mediate  effector phase  (Ts-2) 
suppression (Table IX). This induction of Ts-2 was not only antigen dependent, 
but also antigen specific, as Ts-2 cells were not induced after priming with Ts-1 
plus  SLA.  Thus  it  seems that  Ts-1  lymphocytes can  induce  Ts-2 cells but  that 
this process requires tubular antigen. 
Genetic Restriction Requirements for the Ts-2 Suppressive Effect.  A  genetic anal- 
ysis of the  Igh-1  and  H-2 restrictions imposed on the Ts-2 suppressor response 
was also performed in H-2  s and H-2  d recombinant and congenic mice. Ts-2 ceils 
from SJA (Igh-1 ~) and  SJL (Igh-1 b) mice primed with syngeneic,  SRTA-deriva- 
tized  lymphocytes were  transferred  into  other  immune  H-2  mice of different 
allotype to assess the Igh-1 requirement for afferent and effector phase suppres- 
sion. Transfers within H-2  s mice all produced afferent phase suppression of DTH 
to  SRTA  (Table  X).  When  compared with  controls,  these  results  suggest  that 
Igh-1  differences  between  Ts-1  cells  and  their  recipient  do  not  influence  the 
ability to  mediate afferent phase suppression.  Transfer into  B10.A  (H-2a;  Igh- 
1  b) mice, however, did not produce suppression, indicating that H-2 compatibility 
might be more important. Using the same recombinant mice to examine effector 224  SUPPRESSOR  CELL NETWORKS IN  INTERSTITIAL NEPHRITIS 
TABLE IX 
Induction of Ts2 Suppressor Lyraphocytes by Tsl Cells 
Donor cells harvested from mice*  Recipient im-  Recipient  DTH response 
munization  to SRTA  ~ 
i  RTA/CFA  21.2 + 2.00 
Primed with SRTA-binding Ts-1  RTA/CFA  7.5 -  0.9 
cells + SRTA 
Primed with SRTA-binding Ts-1  RTA/CFA  23.0 -+ 3.6  § 
cells 
Primed with SRTA-binding Ts-I  RTA/CFA  21.3 + 1.70 
cells + SLA 
Primed with control cells +  RTA/CFA  23.8 -+ 2.1 ° 
SRTA 
Primed with control cells  RTA/CFA  21.3 + 1.4  § 
--  CFA  4.3 _+ 2.6 
* Naive SJL mice were intravenously primed with 3 × 106 syngeneic Ts- 
1 or control cells with or without cotransfer of 100 ~g of SRTA or SLA. 
7 d later the spleen cells from these primed recipients were transferred 
into SJL mice previously immunized 5 d earlier. 
~; 36  h after  transfer  the  recipients were footpad challenged (effector 
phase suppression) and an incremental footpad response was measured 
24 h later in inches × 10  -3 +- SEM. 
§  P < 0.001 compared with CFA controls. 
phase  suppression,  we  observed  that  the  Ts-2  effect could  not be  transferred 
across allotype differences,  suggesting that  Ts-2  cells  are  Igh-1  restricted.  We 
examined this latter idea more closely using BALB/c mice congenic in Igh-1. Ts 
cells from BALB/c and C.B-20 mice primed with syngeneic, SRTA-derivatized 
lymphocytes were  transferred  into  immune BALB/c (Igh-C~/V"), C.B-20  (Igh- 
cb/gb),  and  BAB/14  (Igh-Cb/V  a)  recipients  to  measure  Ts-2  effector  phase 
suppression.  Ts-2  suppression  only  occurred  when  Ts  cells  and  the  recipient 
shared homologous Igh-V determinants (Table XI). As before, Ts-2 suppression 
was not demonstrable across a complete H-2 difference. 
Since Ts-2 suppression seems to be the distal and final effector phase process 
in this suppressor network,  we also wished to determine the H-2 restriction on 
this suppressive event. Ts cells from SJL and B 10.S(9R) mice primed with SRTA- 
derivatized lymphocytes were transferred into a variety of immune recombinant, 
Igh-l-identical recipients  to  measure  effector phase  suppression.  Ts cells  from 
SJL mice suppressed the  DTH response to SRTA in B10.HTT and B10.S(8R) 
recipients (Table XII), but not in B 10.S(9R), suggesting that functional homology 
at I-J  s is  required  for suppression.  This restriction was confirmed by the obser- 
vation that Ts cells from B10.S(9R) donors suppressed  in  B10.S(9R) recipients 
but  not  in  B10.HTT.  The  lack  of suppression  in  a  particular  donor-recipient 
combination was not simply due to acute rejection,  since Ts cells  from (SJL  × 
B 10.A)F1 hybrid donors can mediate effector phase suppression in immune SJL 
recipients (data not shown). 
Discussion 
We  have  been  interested  in  developing immunologic strategies  to  alter  the 
natural  history  of immune-mediated  renal  disease  (18,  29,  30).  The  present NEILSON  ET  AL. 
TABLE  X 
Igh-I Restriction of Ts Cells 
225 
Recipients  DTH  Response to SRTA  ~; 
Cells transferred* 
Strain  H-2  Igh-1  Day 0  Day 7 
SJL  s 
SJA/20  s 
B10.S  s 
A.SW  s 
BI0.A  a 
b  SJA/20 Ts  5.5 -  0.2  °  18.3 4- 0.5 
SJL Ts  3.6 -  0.7  ~  5.0 _+ 2.4  ° 
Control  16.0 4- 0.8  19.5 __ 0.9 
a  SJA/20 Ts  3.0 -  2.30  6.5 _+ 2.6  g 
SJL Ts  3.3 +  0.6  §  19.7 4- 7.5 
Control  18.5 _  4.3  17.0 4- 1.5 
b  SJA/20 Ts  5.3 _  0.9  ~  15.7 +  0.7 
SJL Ts  5.0 +  0.7  !  5.3 _  1.0~ 
Control  16.1  _+ 1.0  19.6 +  1.3 
e  SJA/20 Ts  5.3 +  0.50  17.3 _  0.5 
SJL Ts  4.0 _  0.4  a  17.0 +  0.7 
Control  15.6 +  0.5  16.5 _  0.8 
b  SJA/20 Ts  18.8 +  0.5  18.2 +  1.3 
SJL Ts  21.5 -  3.5  17.2 +  0.2 
Control  20.9 +  1.1  16.4 4- 0.7 
*  5  ×  107  donor  cells  from  SJL  or  SJA  mice  primed  with  SRTA-derivatized 
syngeneic lymphocytes were transferred into Igh-l-similar or -disparate recip- 
ients at the time of immunization with RTA/CFA  (afferent phase) or 5 d after 
immunization (effector phase). 
Incremental DTH  responses were measured in the recipient in inches ×  10  -n 
+  SEM. Recipients were challenged for DTH 6 d after transfer (afferent phase) 
or 36 h  after transfer (afferent phase) and the footpad swelling was recorded 
24 h  later. Controls are a  pooled average from all groups. 
P  <  0.001  compared with controls. 
series of experiments examine the interactions and effect of a  tubular antigen- 
induced Ts cell network that can specifically inhibit the expression of nephrito- 
genic effector T  lymphocytes producing interstitial nephritis and DTH to tubular 
antigen  (15).  Our findings indicate that at least two subpopulations of Ts cells 
are involved in this network, and that after 7 d both can be found in the spleens 
of recipients  primed  with  tubular antigen-derivatizedcells.  The  first subset of 
suppressor cells, Ts-1, is Thy-l.2 ÷, L3T4 +, and RE-Id  + (polymorphic idiotype). 
These cells are tubular antigen-binding and only operate, after adoptive transfer, 
if they are present at the time of immunization  (afferent phase suppression).  In 
the  presence  of tubular  antigen,  Ts-1  cells  also  specifically induce  a  second 
subpopulation of Ts cells, Ts-2. Ts-2 cells are Thy-l.2 +, Lyt-2  ÷, and I-J  ÷. They 
are  RE-Id  binding  (antiidiotypic),  only  operate  in  the  effector  phase  of the 
nephritogenic  immune response, and are I-J and Igh-V restricted.  In two addi- 
tional experiments we found no evidence for the presence of a Ts-3 or auxiliary 
subset of suppressor cells (17). 
While  our  suppressor  network  bears  some  resemblance  to  other  hapten- 
reactive  Ts cell  systems induced  by derivatized  lymphocytes (1,  3,  7),  we also 
observed several findings that distinguish it from these other models. Unlike the 226  SUPPRESSOR  CELL  NETWORKS  IN  INTERSTITIAL  NEPHRITIS 
TABLE  XI 
Igh-V Restriction of Ts2 Cells 
Recipients 
Strain  H-2  Igh-Cn  lgh-VH 
DTH  Response to 
Cells transferred*  SRTA* 
BALB/c  d  a  a  BALB/c Ts  5.8 -  0.89 
C.B-20 Ts  17.5 +- 2.5 
Control  15.5 -+ 1.4 
C.B-20  d  b  b  BALB/c Ts  17.8 -+ 1.0 
C.B-20 Ts  6.8 +  1.1§ 
Control  15.3 --+ 0.3 
BAB/14  d  b  a  BALB/c Ts  6,0 +- 1.49 
C.B~20 Ts  17.4 ___ 1.6 
Control  15.8 +- 0.9 
BALB.K  k  a  a  BALB/c Ts  23.0 +  1.9 
C.B-20 Ts  19.5 +  0.6 
Control  20.4 -  0.8 
* 5  x  107  donor  cells  from  BALB/c  or  C,B-20  mice  primed  with  SRTA-derivatized  syngeneic 
lymphocytes were  transferred  into  lgh-l-similar or  -disparate  recipients  5  d  after  immunization 
with RTA/CFA  (effector phase). 
* Incremental DTH  responses were  measured in the recipient in inches x  10  -3 _  SEM.  Recipients 
were challenged for DTH  36 h  after transfer and tbe footpad  swelling was recorded  24 h  later. 
Controls are a pooled average from all groups. 
§ P  <  0.001  compared with controls. 
TABLE  XII 
H-2 Restriction of Effector Phase Ts-2 Cells 
Recipients*  DTH  Response to SRTA after 
suppressor cell transfer* 
H-2 Haplotype 
Strain  SJL  B10.S(9R) 
K  A0  A~  E0  J  E~  D 
SJL  s  s  s  s  s  s  s  5.3 +  0.8  §  -- 
B10.S  s  s  s  s  s  s  s  5.5 +  1.0  §  18.0 +  0.7 
B10.HTT  s  s  s  s  s  k  d  5.8 +  0.90  19.5 -  1.4 
BI0.S(9R)  s  s  s  s  k  k  d  17.3 +  1.1  4.0 -  0.9  j 
B10.S(8R)  k  k  k  k  s  s  s  5.8 +_ 0.69  -- 
B10.A(5R)  b  b  b  b  k  k  d  --  4.7 +  0.30 
B10.A  k  k  k  k  k  k  d  18.3 +- 1.3  5.0 -  0.89 
* 5  x  107  donor  cells  from  SJL  or  B10.S(9R)  mice  primed  with  SRTA-derivatized  syngeneic 
lymphocytes were transferred into H-2-similar or -disparate recipients 5 d after immunization with 
RTA/CFA  (effector phase). 
Incremental DTH  responses were measured in the recipient in inches X  10  -s +  SEM.  Recipients 
were challenged for  DTH  36 h  after transfer and the footpad swelling was recorded  24  h  later. 
Average DTH  response from all groups receiving control cells was 18.3 +  0.5. 
§ P  <  0.001  compared with controls. 
azobenzenearsonate  (ABA)  and  3-nitro-4-hydroxyphenyl  acetyl  (NP)  systems  (1, 
3),  the  nephritogenic  effector  T  cells  producing  DTH  and  interstitial  nephritis 
are  RE-Id  +  (15)  and,  therefore,  share  complementary  specificities  with  Ts-2 
effector  phase  suppressor  cells.  Under  these  conditions  there  might  be  no NE|LSON  ET  AL.  227 
theoretical  necessity  for a  Ts-3  or auxiliary  cell  to  co-mediate  effector phase 
suppressive events. In support of this view we also did not find a CTX-sensitive, 
I-J + Ts-3 cell (17). This finding must be interpreted cautiously, however, as it is 
a negative result, and all Ts-3 cells may not have the same sensitivity to CTX or 
anti-I-J  plus C'.  The  Ts-2  suppression  in our model,  unlike the ABA and  NP 
systems (1, 3), also did not produce a nonspecific or bystander suppression (Table 
VI). Such specificity of the antiidiotypic Ts-2 cell suggests that additional  inter- 
actions with TACC cells are also unlikely (1).  The precise interactions  with the 
target cell of Ts-2 suppression, however, have not been formally defined (work 
in progress), so additional contributions from other lymphocytes cannot be totally 
excluded at this time (see below). It is also interesting  to note that the amount 
of anti-TBM  Ab produced was only slightly affected by Ts-1  suppression,  and 
not by Ts-2 suppression (data not shown). We are currently trying to determine 
whether the production of anti-TBM Ab in disease-protected mice is less over a 
longer period of time,  is of different affinity, or reflects a  phenotypic shift in 
representation of idiotypes that were not defined by RE-anti-Id specificities. 
We  also  observed  that  the  Ts-2  effect  on  DTH  to  tubular  antigen  was 
genetically restricted by I-J and Igh-V determinants.  A role for I-J gene products 
is consistent with the ABA and NP systems (1,  3),  but I-A and K/D restrictions 
have also been  reported  in  other models (31-32).  Although  a  more complete 
definition  of I-J gene  products continues to evolve (1,  34,  35),  their  serologic 
presence and functional  effect were clearly noted in the current  study (Tables 
III, V, and XII). The target of the I-J restricted Ts-2 cell has yet to be established. 
We suspect,  however,  that  the  DTH-reactive,  RE-Id  + cell  is not  I-J  + (work in 
progress), so the Ts-2 suppressive effect, in spite of our failure to implicate a Ts- 
3 cell (see above), may involve more than one cell-mediated interaction or cellular 
target (36). The Igh-V restriction of the antiidiotypic Ts-2 cell was also of interest 
(1,  3).  We  have  previously  observed  (15)  that  the  expression  of  RE-Id  by 
nephritogenic  T  cells is co-defined by an  interactive  effect between H-2K and 
Igh-1  gene  products  in  disease-susceptible mice.  Antiidiotypic  (RE-Id-binding) 
Ts-2  cells from  SJL mice,  in  turn,  can  be isolated in  vitro using either  RE-Id 
from immune SJL (Igh-1 b) or SJA/20 (Igh-1 a) donors, so that direct binding to 
RE-Id by T-2 cells does not seem to depend on heavy chain or minor light chain 
differences. The functional effect of Ts-2 ceils from SJL mice selected by RE-Id 
from  SJA/20  is only observed, however, when  such Ts-2 cells are transferred 
into  immune  SJL,  as  compared  with  SJA  recipients  (data  not  shown).  This 
confirms that  a  unique non-MHC  restriction  determinant  on chromosome  12, 
perhaps Igh-V (Table XI), cofunctions with I-J to facilitate the Ts-2 effect. We 
are presently attempting to serologically characterize this Igh-V gene product. 
The  induction  of  Ts-2  cells  by  purified  Ts-1  lymphocytes  in  our  model 
specifically requires tubular antigen.  This antigen effect can be observed when 
used  in  soluble  form  (Table  IX)  or  when  covalently  linked  to  derivatized 
lympbocytes (Table  I).  In  contrast  to  the  ABA  and  NP  systems  (1,  3),  this 
requirement  for antigen  is  supported  by similar  observations  with  e-glutamic 
acid-L-alanine-L-tyrosine (GAT) and trinitrophenyl (TNP) models of suppression 
(4,  7).  The  Ts-2  cells  in  the  GAT  and  TNP  systems,  however,  are  antigen 
specific, while Ts-2 cells in the ABA and NP systems are idiotype specific. It has 228  SUPPRESSOR  CELL NETWORKS IN  INTERSTITIAL NEPHRITIS 
been recently proposed (7) that immune networks which provide a major idiotype 
produce antiidiotypic Ts-2 cells,  whereas those which do not express a major or 
crossreactive  idiotype,  like  GAT  and  TNP,  express  Ts-2  cells  with  antigen 
specificity (7). While we do not know yet whether the interstitial nephritis model 
produces a major idiotype, it is clear that the idiotypic determinants defined by 
RE-anti-Id  antibodies  are  well  represented  on  both  Lyt-2  +  nephritogenic  T 
lymphocytes (15)  and on Ts-1  cells (Table IV). Our data also indicate that only 
in the presence of tubular antigen can such a regulatory and protective antiidi- 
otypic Ts-2 effect be predictably activated. Thus, the requirement for antigen in 
Ts-2  induction  may operate  under,  yet  to  be  defined rules,  apart  from  the 
presence or absence of a major idiotype on Ts-1  cells. 
Finally, in preliminary studies, we have observed that the Ts cell effect in this 
model of tubulointerstitial disease can be mediated by soluble suppressor factors 
(work in progress); additional biochemical analyses should clarify and enhance 
the present observations. 
Summary 
The nephritogenic effector T  cell response producing interstitial nephritis in 
mice can  be  largely inhibited  by  the  adoptive  transfer of suppressor  T  cells 
before or after the induction of disease. These suppressor T  cells are harvested 
from donor mice primed with tubular antigen-derivatized syngeneic lympho- 
cytes, and two subsets of suppressor cells can be characterized within this donor 
cell population. The first suppressor cell in this network is an L3T4  +, I-J  +, RE- 
Id  + cell (Ts-1).  Ts-1  cells are antigen-binding suppressor cells that inhibit afferent 
phase  immune responses  and,  in  the presence  of tubular antigen, specifically 
induce Lyt-2  +, I-J  + cells (Ts-2) that are antiidiotypic (RE-Id-binding) suppressors. 
The Ts-2 cell is functionally restricted in its suppressive effect by I-J and Igh-V 
gene products, and acts on the effector limb of the cell-mediated anti-tubular 
basement membrane immune response. These studies provide an experimental 
basis  for further efforts to use immunoregulatory modulation in the control of 
autoimmune renal disease. 
We would like to thank Dr. Martin Dorf (Harvard  University) for his helpful discussion 
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